[
    [
        {
            "time": "2023-10-01",
            "original_text": "This High-Yield Dividend Stock Could Outperform If the Stock Market Rallies",
            "features": {
                "keywords": [
                    "High-Yield",
                    "Dividend",
                    "Outperform",
                    "Stock Market",
                    "Rallies"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "This High-Yield Dividend Stock Could Outperform If the Stock Market Rallies",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Why Eli Lilly Stock Is Still Shining in the Darkness",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Stock",
                    "Shining",
                    "Darkness"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Why Eli Lilly Stock Is Still Shining in the Darkness",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Today's Research Reports on Trending Tickers: Dr. Reddy's Laboratories and AbbVie",
            "features": {
                "keywords": [
                    "Research Reports",
                    "Trending Tickers",
                    "Dr. Reddy's Laboratories",
                    "AbbVie"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Today's Research Reports on Trending Tickers: Dr. Reddy's Laboratories and AbbVie",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]